# EDGAR Filing Document

**Accession Number:** 0000724004
**File Stem:** 0001437749-23-000281
**Filing Date:** 2023-1
**Character Count:** 5677
**Document Hash:** 7d692dad71724c09d242c5ea2d555c6d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-000281.hdr.sgml**: 20230104

**ACCESSION NUMBER**: 0001437749-23-000281

**CONFORMED SUBMISSION TYPE**: 8-K/A

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20220826

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20230104

**DATE AS OF CHANGE**: 20230104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MESA LABORATORIES INC /CO/
- **CENTRAL INDEX KEY:** 0000724004
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
- **IRS NUMBER:** 840872291
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-11740
- **FILM NUMBER:** 23505523

**BUSINESS ADDRESS:**
- **STREET 1:** 12100 W 6TH AVE
- **CITY:** LAKEWOOD
- **STATE:** CO
- **ZIP:** 80228
- **BUSINESS PHONE:** 3039878000

**MAIL ADDRESS:**
- **STREET 1:** 12100 W 6TH AVE
- **CITY:** LAKEWOOD
- **STATE:** CO
- **ZIP:** 80228

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MESA LABORATORIES INC /CO
- **DATE OF NAME CHANGE:** 19951117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MESA MEDICAL INC
- **DATE OF NAME CHANGE:** 19921123

mlab20230104_8ka.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM **8-K/A**

**Amendment No. 1**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **<u>August 26, 2022</u>**

**MESA LABORATORIES, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **<u>Colorado</u>**<br> (State or other jurisdiction of<br> incorporation) | **<u>0-11740</u>**<br> (Commission File Number) | <u>**<u>84-0872291</u>**</u> <br> (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **<u>**<u>12100 West Sixth Avenue</u>**,</u>** <br> **<u>**<u>Lakewood</u>**,</u> <u>Colorado</u>**<br> (Address of principal executive offices) | <u>**<u>80228</u>**</u><br> (Zip Code) |

---

Registrant's telephone number, including area code**: **303**-**987-8000**

**<u>Not Applicable</u>**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which**<br> **registered** |
| Common Stock, no par value | MLAB | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**EXPLANATORY NOTE**

On August 26, 2022, Mesa Laboratories, Inc. (the "Company") filed a Current Report on Form 8-K (the "Initial 8-K") disclosing the voting results of the Annual Meeting of Shareholders of Mesa Laboratories, Inc. held on August 26, 2022. The Initial 8-K failed to include the results for the non-binding, advisory vote regarding the frequency of voting on the compensation paid to the Company's named executive officers. Voting results are included below. Additionally, this Current Report on Form 8-K discloses the Company's decision as to the frequency of future say-on-pay votes.

Except as described above, all other information in the Initial 8-K remains unchanged.

**ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS**

The non-binding, advisory vote regarding the frequency of voting on the compensation paid to the Company's named executive officers was in favor of voting every one year:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Every 1 Year** | **Every 2 Years** | **Every 3 Years** | **Abstain** | **Broker Non-Votes** |
| 4,330,300 | 6,130 | 43,642 | 2,849 | 296,490 |

---

In light of the votes cast in favor of "one year" as the preferred frequency of future advisory votes on executive compensation, the Board of Directors has determined that the Company will include a shareholder advisory vote on the compensation of executives in its proxy materials each year until the next required vote on the frequency of shareholder advisory votes on the compensation of executives.

**SIGNATURE** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| DATE: January 4, 2023 |  | Mesa Laboratories, Inc. |
|  |  | (Registrant) |
|  | BY:  | /s/ Gary M. Owens  |
|  |  | Gary M. Owens |
|  |  | President and Chief Executive Officer |

---